Lack of acquired resistance in HER2-positive breast cancer cells after long-term HER2 siRNA nanoparticle treatment.
about
Lack of acquired resistance in HER2-positive breast cancer cells after long-term HER2 siRNA nanoparticle treatment.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh
2018年學術文章
@zh-hant
name
Lack of acquired resistance in ...... siRNA nanoparticle treatment.
@en
Lack of acquired resistance in ...... siRNA nanoparticle treatment.
@nl
type
label
Lack of acquired resistance in ...... siRNA nanoparticle treatment.
@en
Lack of acquired resistance in ...... siRNA nanoparticle treatment.
@nl
prefLabel
Lack of acquired resistance in ...... siRNA nanoparticle treatment.
@en
Lack of acquired resistance in ...... siRNA nanoparticle treatment.
@nl
P2093
P2860
P1433
P1476
Lack of acquired resistance in ...... siRNA nanoparticle treatment.
@en
P2093
Joe W Gray
Moataz Reda
Wassana Yantasee
Worapol Ngamcherdtrakul
P2860
P304
P356
10.1371/JOURNAL.PONE.0198141
P407
P50
P577
2018-06-07T00:00:00Z